Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Particle-based delivery of the HIV envelope protein
Benedikt Asbach, Ralf Wagner
Current Opinion in HIV and AIDS (2017) Vol. 12, Iss. 3, pp. 265-271
Open Access | Times Cited: 18

Showing 18 citing articles:

Glycosylation in health and disease
Colin Reily, Tyler J. Stewart, Matthew B. Renfrow, et al.
Nature Reviews Nephrology (2019) Vol. 15, Iss. 6, pp. 346-366
Open Access | Times Cited: 1587
Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimers as HIV-1 vaccine candidates
Yi-Nan Zhang, Jennifer Paynter, Aleksandar Antanasijevic, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1
Yong Gao, Chanuka N. Wijewardhana, Jamie F. S. Mann
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 71
Rational design of next-generation filovirus vaccines with glycoprotein stabilization, nanoparticle display, and glycan modification
Yi-Zong Lee, Yi-Nan Zhang, Maddy L. Newby, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Production of HIV-1-based virus-like particles for vaccination: achievements and limits
Laura Cervera, Francesc Gòdia, Ferran Tarrés-Freixas, et al.
Applied Microbiology and Biotechnology (2019) Vol. 103, Iss. 18, pp. 7367-7384
Closed Access | Times Cited: 43
Neutralizing Antibody Induction by HIV-1 Envelope Glycoprotein SOSIP Trimers on Iron Oxide Nanoparticles May Be Impaired by Mannose Binding Lectin
Rajesh P. Ringe, Victor M. Cruz Portillo, Pia Dosenovic, et al.
Journal of Virology (2019) Vol. 94, Iss. 6
Open Access | Times Cited: 34
Critical design criteria for engineering a nanoparticulate HIV-1 vaccine
Stefanie Thalhauser, David Peterhoff, Ralf Wagner, et al.
Journal of Controlled Release (2019) Vol. 317, pp. 322-335
Closed Access | Times Cited: 23
Presentation of HIV-1 Envelope Trimers on the Surface of Silica Nanoparticles
Stefanie Thalhauser, David Peterhoff, Ralf Wagner, et al.
Journal of Pharmaceutical Sciences (2019) Vol. 109, Iss. 1, pp. 911-921
Open Access | Times Cited: 22
Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination
Zekun Mu, Barton F. Haynes, Derek W. Cain
Current Opinion in Virology (2021) Vol. 51, pp. 172-178
Open Access | Times Cited: 17
Advantages and Limitations of Integrated Flagellin Adjuvants for HIV-Based Nanoparticle B-Cell Vaccines
Cornelia Barnowski, Nicole P. Kadzioch, Dominik Damm, et al.
Pharmaceutics (2019) Vol. 11, Iss. 5, pp. 204-204
Open Access | Times Cited: 19
Induction of Tier 1 HIV Neutralizing Antibodies by Envelope Trimers Incorporated into a Replication Competent Vesicular Stomatitis Virus Vector
Christiane Anika Bresk, Tamara Hofer, Sarah Wilmschen, et al.
Viruses (2019) Vol. 11, Iss. 2, pp. 159-159
Open Access | Times Cited: 16
Mass spectrometry for the identification and analysis of highly complex glycosylation of therapeutic or pathogenic proteins
Yukako Ohyama, Kazuki Nakajima, Matthew B. Renfrow, et al.
Expert Review of Proteomics (2020) Vol. 17, Iss. 4, pp. 275-296
Open Access | Times Cited: 15
CD4+ T Cells Induced by Tuberculosis Subunit Vaccine H1 Can Improve the HIV-1 Env Humoral Response by Intrastructural Help
Stephan Klessing, Vladimir Temchura, Pierre Tannig, et al.
Vaccines (2020) Vol. 8, Iss. 4, pp. 604-604
Open Access | Times Cited: 12
Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery
David Peterhoff, Stefanie Thalhauser, Jan M. Sobczak, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 642-642
Open Access | Times Cited: 10
Immunogenicity of a silica nanoparticle-based SARS-CoV-2 vaccine in mice
Clara Barbey, Jinpeng Su, Martina Billmeier, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 192, pp. 41-55
Open Access | Times Cited: 1
Discussion on the influence of nanoparticle characteristics in New Coronavirus Disease-19 and severe acute respiratory syndrome Coronavirus 2
Shenguo Wang
International Journal of Nanomaterials Nanotechnology and Nanomedicine (2021), pp. 038-042
Open Access | Times Cited: 2
Possible Effect of Nano Characterization of COVID-19 on Infection and Causing Disease
Shenguo Wang
International Journal of Medical Nano Research (2023) Vol. 10, Iss. 1
Open Access

Shenguo Wang
International Journal of Medical Nano Research (2023) Vol. 10, Iss. 1
Open Access
Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimers as HIV-1 vaccine candidates
Yi-Nan Zhang, Jennifer Paynter, Aleksandar Antanasijevic, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top